Pharmabiz

Indraprastha Apollo Hospitals marks World Physiotherapy Day 2026 with Move More, Live Healthier initiative

Indraprastha Apollo Hospitals marks World Physiotherapy Day 2026 with Move More, Live Healthier initiative: Our Bureau, Mumbai Wednesday, September 9, 2026, 14:45 Hrs [IST] To mar ...
Pharmabiz

Alkem launches Renocia Exo, next-generation hair regeneration therapy

Alkem Laboratories Ltd. announced the launch of Renocia Exo, a next-generation hair regeneration therapy developed to support the health and vitality of the hair follicle through a comprehensive ...
Pharmabiz

Biocon bags 10-year supply contract for pertuzumab in Brazil

Biocon, has inked a partnership agreement with Bahiafarma and Bionovis for pertuzumab in Brazil, marking an important milestone in advancing production and commercialisation of the HER2-positive ...
Pharmabiz

Ascletis Pharma initiates phase I study in US for oral amylin receptor peptide agonist ASC36 to treat obesity

Ascletis Pharma initiates phase I study in US for oral amylin receptor peptide agonist ASC36 to treat obesity: Hong Kong Wednesday, September 9, 2026, 13:00 Hrs [IST] Ascletis Pha ...
Pharmabiz

India’s clinical excellence and 60–80% lower healthcare costs offer huge potential to serve the world: Piyush Goyal

India’s clinical excellence and 60–80% lower healthcare costs offer huge potential to serve the world: Piyush Goyal: Our Bureau, Mumbai Wednesday, September 9, 2026, 13:50 Hrs ...
Pharmabiz

US FDA approves Abbott’s TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms

US FDA approves Abbott’s TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms: Abbott Park, Illinois Wednesday, September 9, 2026, 14:00 Hrs [IST] Abbott, ...
Pharmabiz

CDSCO shifting towards smarter, risk-based regulation: Dr Ranga Chandrashekhar

The Central Drugs Standard Control Organisation (CDSCO) is moving towards a smarter, risk-based regulatory approach that reduces and prioritises intervention, simplifies processes and applies greater ...
Pharmabiz

BMJ Research Forum South Asia 2026 calls for research that changes lives

BMJ Research Forum South Asia 2026, was held in New Delhi under the theme “Driving Real-World Impact from Health Research in ...
Pharmabiz

Karnataka FSDA bags Certificate of Appreciation for regulatory excellence

Karnataka FSDA bags Certificate of Appreciation for regulatory excellence: Our Bureau, Bengaluru Tuesday, September 8, 2026, 17:15 Hrs [IST] The Karnataka Food Safety and Drug Adm ...
Pharmabiz

Onyx Scientific invests £1.5 million to expand commercial API production capacity at UK facility

Onyx Scientific invests £1.5 million to expand commercial API production capacity at UK facility: Newcastle, UK Wednesday, September 9, 2026, 12:00 Hrs [IST] Onyx Scientific, a g ...
Pharmabiz

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint: Basel Wednesday, September 9, 2026, 09:00 Hrs [IST] No ...
Pharmabiz

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition: Our Bureau, Bengaluru Wednesday, September 9, 2026, 10:00 Hrs [IST] Leucine Rich Bio, South Asia’ ...